SEC 13F Intelligence

Stevens Capital Management LP / BSX

Stevens Capital Management LP’s Boston Scientific Corp Position

Does Stevens Capital Management LP own Boston Scientific Corp (BSX)? Not currently — the last reported position was 53.8K shares worth $5M in Q4 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$5M
Q4 2025
Shares
53.8K
% of Portfolio
+1.80%
Quarters Held
9
position exited

Position History BSX

Reported value by quarter
Q3 ’19: $4MQ3 ’19Q1 ’21: $356,000Q2 ’21: $543,000Q2 ’21Q3 ’24: $1MQ4 ’24: $677,000Q4 ’24Q1 ’25: $664,000Q2 ’25: $4MQ2 ’25Q3 ’25: $7MQ4 ’25: $5MQ4 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q4 202553.8K$5M+1.80%
Q3 202572.3K$7M+0.94%
Q2 202535.5K$4M+1.04%
Q1 20256.6K$664,000+0.16%
Q4 20247.6K$677,000+0.27%
Q3 202413.8K$1M+0.17%
Q2 202112.7K$543,000+0.16%
Q1 20219.2K$356,000+0.20%
Q3 2019106.4K$4M+0.39%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Stevens Capital Management LP’s full portfolio or all institutional holders of BSX.